Anxiety symptoms in crack cocaine and inhalant users admitted to a psychiatric hospital in southern Brazil

Revista da Associação Médica Brasileira

Carlos Zubaran²  Katia Foresti¹  Mariana Rossi Thorell¹  Paulo Roberto Franceschini¹ 

[1] ,University of Western Sydney School of Medicine Sydney,Australia

关键词: Crack cocaine;    Solvents;    Anxiety Brazil;    Questionnaires;    Crack;    Solventes;    Ansiedade;    Brasil;    Questionários;   

DOI  :  10.1016/j.ramb.2013.01.008

来源: SciELO

【 摘 要 】

OBJECTIVE: The occurrence of psychiatric comorbidity among individuals with crack or inhalant dependence is frequently observed. The objective of this study was to investigate anxiety symptoms among crack cocaine and inhalant users in southern Brazil. METHODS: The study investigated two groups of volunteers of equal size (n = 50): one group consisted of crack cocaine users, and the other group consisted of inhalant users. Research volunteers completed the Portuguese versions of the State-Trait Anxiety Inventory (STAI), Hamilton Anxiety Rating Scale (HAM-A), and Self-Report Questionnaire (SRQ). RESULTS: Both crack and inhalant users experience significant symptoms of anxiety. Inhalant users presented significantly more anxiety symptoms than crack users according to the HAM-A questionnaire only. In contrast to the results of the HAM-A, the STAI failed to demonstrate a significant difference between the two groups of substance users. SRQ scores revealed that crack and inhalants users had significant degrees of morbidity. CONCLUSION: A significant difference regarding anxiety symptomatology, especially state anxiety, was observed among inhalant and crack users. Anxiety and overall mental psychopathology were significantly correlated in this sample. The results indicate that screening initiatives to detect anxiety and additional psychiatric comorbidities among crack and inhalant users are feasible and relevant.

【 授权许可】

CC BY-NC   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License